
Advances in supercomputing to analyze big data and the role of virtual reality (VR) in pain management highlight this year’s TechMed sub-track. On Tuesday, Nov. 7, the chief medical officer […]
The ACR/ARHP Annual Meeting has many great opportunities to network with colleagues and others in the field. Here are a few ways to connect during the Annual Meeting. Opening Reception: […]
Attendees of Friday’s half-day, pre-meeting course, 2017 MOC Annual Meeting Course — ABIM 2017 Update in Rheumatology, will get an in-depth review of a medical knowledge module developed by the American […]
Arnold Ceponis, MD, PhD, Associate Clinical Professor, Rheumatology Training Program Director, University of California, San Diego, Division of Rheumatology, Allergy & Immunology, and Tania L. Rivera, MD, of the Rheumatology Center of San Diego, shared some of their favorite places to take visitors to San…
The annual ‘Thieves’ Market: Show Me Your Best Cases’ features a series of mysterious clinical cases pertaining to rheumatology. Physicians this year shared their stories of patients experiencing symptoms ranging from loose teeth to pale hands to an increased stroke risk.
This year’s Great Debate focused on the value of tapering biologic DMARDs (bDMARDs) in patients with rheumatoid arthritis who have achieved low disease activity (LDA).
Anakinra, an interleukin antagonist commonly used in the treatment of rheumatoid arthritis, is also used for other inflammatory diseases and recently has been studied as a treatment with chemotherapy for some cancers, according to Charles Dinarello, MD, who presented the Rheumatology Research Foundation Philip Hench,…
“A big part of the crisis has to do with how we use bisphosphonates safely and effectively,” said Kenneth G. Saag, MD, MSc, the Jane Knight Lowe Professor and Vice Chair of Medicine and Director of the Center for Outcomes, Effectiveness Research, and Education at…
Make it three Knowledge Bowl championships in three years for The Hawkeyes from the University of Iowa.
“We have a specific commitment to the next generation of clinician scientists,” said Stephen I. Katz, MD, PhD, Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH.